[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100550281":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":13,"locations":22,"responsibleParty":38,"collaborators":40,"id":43,"slug":44,"hasResults":45,"nctId":46,"briefTitle":47,"officialTitle":47,"acronym":48,"eligibilityCriteria":49,"healthyVolunteers":45,"sex":50,"minAge":7,"maxAge":7,"enrollmentInfo":51,"targetDuration":54,"studyType":55,"phases":7,"briefSummary":56,"conditions":57,"keywords":60,"overallStatus":64,"whyStopped":7,"lastUpdateSubmitDate":65,"lastUpdatePostDateStruct":66,"startDateStruct":69,"completionDateStruct":71,"leadSponsor":73,"locationsCount":74},{"fullName":5,"class":6},"Dacima Consulting","OTHER",null,[9],{"name":10,"affiliation":11,"role":12},"Nabila Rekik Mejdoub, MD","Société Tunisienne D'endocrinologie De Diabétologie Et Des Maladies Métaboliques","STUDY_CHAIR",[14,18],{"name":10,"role":15,"phone":16,"phoneExt":7,"email":17},"CONTACT","+216 98 609 300","nabila.rekik.mejdoub@gmail.com",{"name":19,"role":15,"phone":20,"phoneExt":7,"email":21},"Rabie Razgallah, MD","+216 20 509 729","rabie.razgallah@evidentiq.com",[23],{"facility":11,"status":7,"city":24,"state":25,"zip":26,"country":25,"countryCode":27,"cosmosGeoPoint":28,"geoPoint":33,"contacts":34},"Sfax","Tunisia","3000","TN",{"type":29,"coordinates":30},"Point",[31,32],10.76028,34.74056,{"lat":32,"lon":31},[35,36],{"name":10,"role":15,"phone":16,"phoneExt":7,"email":17},{"name":19,"role":15,"phone":20,"phoneExt":7,"email":37},"rabie.razgallah@evideniq.com",{"type":39,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR",[41],{"name":11,"class":42},"UNKNOWN","100550281","tunisian-clinical-registry-on-hypoparathyroidism-and-pseudo-hypoparathyroidism-100550281",false,"NCT06445036","Tunisian Clinical Registry on Hypoparathyroidism and Pseudo-hypoparathyroidism","THYPARS","Inclusion Criteria:\n\n* Hypoparathyroidism defined by low serum calcium \\\u003C 2.2 mmol\u002Fl (\\\u003C 88 mg\u002Fl) associated with inadequate PTH (low or normal) and normal creatinine\n\nExclusion Criteria:\n\n* Cervical surgery \\\u003C 6 months.\n* Transient (neonatal, etc.) or functional (dysmagnesemia, etc.) hypoparathyroidism.\n* Other causes of hypocalcemia: vitamin D deficiency, chronic renal failure, etc.\n* Familial hypocalcemia hypercalciuria.\n* Pseudo-pseudo-hypoparathyroidism.","ALL",{"count":52,"type":53},1000,"ESTIMATED","1 Day","OBSERVATIONAL","Observational, multicenter, national, cross-sectional study aiming to describe the epidemiological clinical, biological and therapeutic profile of patients suffering from defect in secretion (hypoparathyroidism) or action (pseudo-hypoparathyroidism) of parathyroid hormone.",[58,59],"Hypoparathyroidism","Pseudo Hypoparathyroidism",[58,59,61,62,63],"Clinical Registry","Endocrinology","Parathyroid gland","NOT_YET_RECRUITING","2025-02-20",{"date":67,"type":68},"2025-02-21","ACTUAL",{"date":70,"type":53},"2025-02-27",{"date":72,"type":53},"2025-07-27",{"name":5,"class":6},1]